These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11877850)

  • 1. [What should be the target of therapy in the adult-onset diabetes mellitus?].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1119-20. PubMed ID: 11877850
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of hyperglycemia and the prognosis of adult-onset diabetes mellitus].
    Niskanen L; Uusitupa M; Laakso M
    Duodecim; 1999; 115(10):1122-4. PubMed ID: 11877851
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of patients with diabetes mellitus type 2 and coronary artery disease].
    Wiersma JJ; Trip MD; Piek JJ
    Ned Tijdschr Geneeskd; 2006 Feb; 150(7):361-6. PubMed ID: 16523798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing cardiovascular complications of type 2 diabetes by targeting multiple risk factors.
    Reasner CA
    J Cardiovasc Pharmacol; 2008 Aug; 52(2):136-44. PubMed ID: 18670366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of hyperglycemia in adult-onset diabetes mellitus].
    Yki-Järvinen H
    Duodecim; 1999; 115(10):1155-64. PubMed ID: 11877855
    [No Abstract]   [Full Text] [Related]  

  • 6. Initiating insulin in type 2 diabetes mellitus: the earlier the better.
    Cohen O
    Isr Med Assoc J; 2004 May; 6(5):292-4. PubMed ID: 15151371
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
    Goldberg RB; Fonseca VA; Truitt KE; Jones MR
    Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
    Syvänne M
    Duodecim; 1999; 115(10):1167-73. PubMed ID: 11877856
    [No Abstract]   [Full Text] [Related]  

  • 9. Adiposopathy, diabetes mellitus, and primary prevention of atherosclerotic coronary artery disease: treating "sick fat" through improving fat function with antidiabetes therapies.
    Bays HE
    Am J Cardiol; 2012 Nov; 110(9 Suppl):4B-12B. PubMed ID: 23062567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapies for type 2 diabetes and coronary artery disease.
    DeVries JH
    N Engl J Med; 2009 Oct; 361(14):1408-9; author reply 1409-10. PubMed ID: 19802918
    [No Abstract]   [Full Text] [Related]  

  • 11. Glycemic treatment in type 1 and type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2006 Nov; 29(11):2549-55. PubMed ID: 17065700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical advances in diabetes].
    Martin S; Scherbaum WA
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1461-2. PubMed ID: 16794976
    [No Abstract]   [Full Text] [Related]  

  • 13. Systematic strategies for improved outcomes for the hyperglycemic hospitalized patient with diabetes mellitus.
    Vasa F
    Am J Cardiol; 2005 Aug; 96(4A):41E-46E. PubMed ID: 16098843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of insulin on endothelial function, inflammation, and atherogenesis and their implications.
    Kuritzky L; Nelson SE
    J Fam Pract; 2005 Jun; 54(6):S7-9. PubMed ID: 16021783
    [No Abstract]   [Full Text] [Related]  

  • 15. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Mannucci E; Monami M; Pala L; Cocca C; Cresci B; Bardini G; Masotti G; Marchionni N; Rotella CM
    Diabetes Care; 2007 Jan; 30(1):193-4. PubMed ID: 17192373
    [No Abstract]   [Full Text] [Related]  

  • 16. [Coronary artery disease in diabetic patients].
    Henry P
    Rev Prat; 2008 Sep; 58(14):1561-4. PubMed ID: 18839684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.
    Porta M; Trento M
    Diabetes Care; 2007 Jan; 30(1):193; author reply 194-6. PubMed ID: 17192374
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus.
    Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
    Am J Cardiol; 2006 Mar; 97(5):646-50. PubMed ID: 16490430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.
    Nathanson D; Nyström T
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):112-26. PubMed ID: 19038307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.